Cardiotoxicity of immune checkpoint inhibitors

Cardiac toxicity after conventional antineoplastic drugs (eg, anthracyclines) has historically been a relevant issue. In addition, targeted therapies and biological molecules can also induce cardiotoxicity. Immune checkpoint inhibitors are a novel class of anticancer drugs, distinct from targeted or...

Descripción completa

Detalles Bibliográficos
Autores principales: Varricchi, Gilda, Galdiero, Maria Rosaria, Marone, Giancarlo, Criscuolo, Gjada, Triassi, Maria, Bonaduce, Domenico, Marone, Gianni, Tocchetti, Carlo Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663252/
https://www.ncbi.nlm.nih.gov/pubmed/29104763
http://dx.doi.org/10.1136/esmoopen-2017-000247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663252/
https://www.ncbi.nlm.nih.gov/pubmed/29104763
http://dx.doi.org/10.1136/esmoopen-2017-000247

Ejemplares similares